SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Canopy Growth Corp (NASDAQ:CGC)

Canada · Delayed Price · Currency is USD
0.88-0.01 (-1.59%)
 
Market Cap370.02M-39.5%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out422.15M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,228,136
Open0.89
Previous Close0.89
Day's Range0.86 - 0.89
52-Week Range0.84 - 2.38
Betan/a
AnalystsHold
Price Target14.47(+1550.88%)
Earnings Daten/a
Insider Score
––Not scored
CGC Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About CGC

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Address
1 Hershey Drive, Smiths Falls, ON, K7A 0A8, Canada
Market Cap
370 million
Employees
1,128
Industrial Classification
Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$454.45K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-1.57%
5 Days
-2.12%
1 Month
-9.21%
6 Months
-15.67%
1 Year
-39.52%

$CGC stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CGC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CGC's directors and management

Net Shares Purchased by Insiders−300k−150k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CGC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CGC Revenue by Segment or Geography

CGC's latest filing doesn't break out revenue by segment.

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CGC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CGC from public contracts

Source: USAspending.gov

CGC Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for CGC is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from CGC’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
25
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.